Know Cancer

or
forgot password


N/A
2 Years
9 Years
Not Enrolling
Both
Pervasive Child Development Disorders, Autism

Thank you

Trial Information


PROTOCOL OUTLINE:

Patients are evaluated with the following questionnaires at ages 2-3 years and again at ages
5-9: The Autism Diagnostic Interview (ADI); The Autism Diagnostic Observation Schedule
(ADOS); Assessment of cognitive functioning; Expressive and receptive language; Adaptive
functioning; Measures of burden and functional assessment; The Aberrant Behavior Checklist;
The Connors Rating Scale - Parent and Teacher version; and Autism Behavior Checklist

An MRI and EEG are performed, and blood samples are collected from patients and family
members for molecular genetic studies.

Inclusion Criteria


- Psychologically diagnosed (DSM-IV) as Childhood Disintegrative Disorder

- No known genetic or medical syndrome (Down syndrome or cerebral palsy)

- Must speak English

Type of Study:

Observational

Study Design:

Primary Purpose: Screening, Time Perspective: Longitudinal

Principal Investigator

Fred Volkmar

Investigator Role:

Study Chair

Investigator Affiliation:

Yale University

Authority:

United States: Federal Government

Study ID:

199/13682

NCT ID:

NCT00004458

Start Date:

May 1997

Completion Date:

Related Keywords:

  • Pervasive Child Development Disorders
  • Autism
  • autism
  • childhood disintegrative disorder
  • neurologic and psychiatric disorders
  • rare disease
  • Autistic Disorder
  • Developmental Disabilities
  • Child Development Disorders, Pervasive

Name

Location

University of Chicago Cancer Research CenterChicago, Illinois  60637
Yale Child Study CenterNew Haven, Connecticut  06520